1 completed, 1 terminated, 1 unknown. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow sonepcizumab: new trials by email Literature Review of sonepcizumab trials Research Report on sonepcizumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV) iSONEP (sonepcizumab/LT1009) - Pigment Epithelial Detachment | Phase 1 | Terminated | Lpath, Inc. | 12 | 2011-03-01 | 2013-04-23 |
| Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration iSONEP - Neovascular Age Related Macular Degeneration | Phase 1 | Unknown | Lpath, Inc. | 15 | 2008-10-01 | 2012-04-16 |
| Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors ASONEP (sonepcizumab/LT1009) - Solid Tumors | Phase 1 | Completed | Lpath, Inc. | 37 | 2008-04-01 | 2012-01-31 |
Neoplasms (1) · Polypoidal Choroidal Vasculopathy (1) · Retinal Detachment (1)
Lpath, Inc. (3)
United States (3)
Glenn Stoller, MD (2) · William Garland, PhD (1)